Resources - general public
Adolescent meningococcal ACWY vaccine – brochure (Tagalog)
Brochure
This brochure provides information (in Tagalog) about the meningococcal ACWY vaccine, available free for adolescents.
Adolescent meningococcal ACWY vaccine – brochure (Vietnamese)
Brochure
This brochure provides information (in Vietnamese) about the meningococcal ACWY vaccine, available free for adolescents.
Protecting your baby against influenza starts when you’re pregnant – brochure
Brochure
This brochure provides information about influenza vaccination in pregnancy.
Adolescent meningococcal ACWY vaccine – brochure
Brochure
This brochure provides information about the meningococcal ACWY vaccine, available free for adolescents.
Adolescent meningococcal ACWY vaccine – poster
Poster
This poster provides information about the meningococcal ACWY vaccine, available free for adolescents.
ATAGI Bulletin for the 68th Meeting, 14-15 February 2019
Meeting minutes
Australian Technical Advisory Group on Immunisation (ATAGI) Bulletin for the 68th Meeting held on 14 and 15 February 2019.
Protect your baby from whooping cough. Vaccinate for free when pregnant – poster
Poster
This poster aims to prompt pregnant women to think about getting the free whooping cough vaccine when pregnant.
National Immunisation Strategy for Australia 2019 to 2024
Strategy or framework
The National Immunisation Strategy 2019-2024, builds upon the success of the first National Immunisation Strategy 2013-2018. The Strategy comprises eight strategic priority areas to complement and strengthen the National Immunisation Program.
Vaccine safety in Australia AusVaxSafety summary report 2016-17
Report
AusVaxSafety is a national system for monitoring vaccine safety in Australia. The report shows how parents and carers responded to the SMS about their child's health a few days after their vaccination at each schedule point in the National Immunisation Program (NIP) in Australia in 2016-17.
2 months schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 2 month vaccinations.
4 months schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 4 month vaccinations.
6 months schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 6 month vaccinations.
12 months schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 12 month vaccinations.
18 months schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 18 month vaccinations.
4 years schedule point - Vaccine safety in Australia 2016–17
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 4 year vaccinations.
12 and 18 months schedule point - Extra vaccines for Aboriginal and Torres Strait Islander children
Infographic
The AusVaxSafety system actively monitors vaccine safety throughout Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child's health a few days after their 12 and 18 month vaccinations.
Community attitude research on influenza vaccination – Quantitative research report
Report
Research reports on quantitative research conducted on community attitudes and behaviours regarding the influenza vaccine.
National coverage rates for Aboriginal and Torres Strait Islander children
Infographic
Immunisation coverage for 1 and 5 year olds has increased since 2009. We have reached the target of 95% for Aboriginal and Torres Strait Islander 5 year olds.
National coverage rates for all children
Infographic
Immunisation coverage for 1, 2 and 5 year olds has increased since 2008.
ATAGI terms of reference
Terms of reference
The terms of reference for the Australian Technical Advisory Group on Immunisation (ATAGI).
National Immunisation Program (NIP) vaccine listing process
Procedure
The National Immunisation Program (NIP) vaccine listing process sets out the regulatory steps that must occur in order for a vaccine to be supplied through the NIP.
Evaluation of the National HPV Program final report
Report
The evaluation was extremely positive and strongly supported Australia’s reputation as a world leader in implementing school-based immunisation programs and preventing HPV-related cancers and disease.
COVID-19 response update for General Practitioners – 6 May 2021
-
Webinar
This webinar on 6 May is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants' questions.
COVID-19 response update for General Practitioners – 27 May 2021
-
Webinar
This webinar on 27 May is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
COVID-19 response update for General Practitioners – 8 July 2021
-
Webinar
This webinar on 8 July is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
Date last updated:
Tags: